Key Takeaways
- Shares of Meta climbed 2% Tuesday morning before settling at a 0.75% gain following Bloomberg’s report on the company’s custom AI chip deployment scheduled for early 2027.
- The processor, designated MTIA 450 or Arke, represents Meta’s third-generation proprietary chip developed alongside Broadcom and TSMC.
- An advanced fourth-generation processor, named Astrid, will complete its design phase within approximately 30 days and reach operational facilities by late 2027.
- This strategic initiative targets decreased dependency on Nvidia hardware while lowering energy consumption and infrastructure expenses.
- Wall Street analysts maintain a Strong Buy consensus on META stock with a mean price target of $758.03, suggesting 13.5% potential upside.
Meta Platforms (META) shares experienced upward momentum Tuesday, initially jumping 2% following a Bloomberg report revealing the social media giant’s intention to deploy proprietary AI processors across its data center infrastructure during the first six months of 2027. The stock subsequently moderated its advance to approximately 0.75%.
The processor generating market attention is designated MTIA 450, alternately referred to as Arke. This marks the third iteration within Meta’s proprietary semiconductor initiative, which the company initially unveiled in 2023.
Meta currently has the Arke processor in its testing phase. A subsequent fourth-generation variant, internally designated Astrid, is projected to complete its design cycle within 30 days and become operational in data facilities by December 2027.
Yee Jiun Song, who serves as Meta’s vice president of engineering and leads the custom semiconductor program, informed Bloomberg that successive chip generations consistently achieve superior performance metrics per watt of energy consumed and per dollar invested when benchmarked against commercially available alternatives.
Song further indicated that these processors can execute AI models with greater efficiency than existing Nvidia solutions, especially for inference operations—the phase where AI systems produce real-time responses to user queries.
Lessening Nvidia Hardware Reliance
Meta engineered these processors through collaboration with Broadcom handling design responsibilities and Taiwan Semiconductor Manufacturing (TSMC) managing production. The strategic objective centers on diminishing the company’s dependence on Nvidia components for executing AI computational tasks.
Meta has allocated resources for more than one gigawatt of its proprietary processors across a 12-month timeframe. Song emphasized that at such operational magnitude, tolerating a 30% cost elevation becomes financially unfeasible, underscoring the importance of internally developed solutions.
The initial dozen test processors arrived from TSMC on September 1. Actual performance metrics aligned within 2% to 3% of preliminary design projections. Immediately upon receipt, engineering teams executed Meta’s proprietary AI models alongside applications from DeepSeek and Alibaba.
Prioritizing Inference Capabilities
Meta previously pursued development of a processor called Olympus, scheduled for 2028 or 2029 deployment, which was conceived to manage both model training and inference operations. The company terminated that initiative based on cost considerations.
The present semiconductor roadmap concentrates exclusively on inference capabilities, maintaining reduced expenses while satisfying Meta’s requirements for operating AI systems at massive scale.
Meta Superintelligence Labs contributes to this effort by communicating forthcoming model specifications with the engineering division, enabling chip designs aligned with practical deployment scenarios.
Tuesday’s stock appreciation extends recent positive movement following Meta’s introduction of the Muse AI agent.
Based on data from TipRanks, META stock carries a Strong Buy consensus rating derived from 44 analyst assessments published within the last three months. The distribution includes 38 Buy recommendations and six Hold ratings.
The mean price target over the next 12 months reaches $758.03, indicating potential appreciation of 13.5% from present trading levels.


